Dyadic International (DYAI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
Meeting formally opened by the Chairman, with introductions of board members, executive team, auditors, and legal counsel.
Safe harbor disclosure regarding forward-looking statements and associated risks was provided.
Agenda included addressing shareholder proposals, voting, and a strategic update presentation.
Board and executive committee updates
Board members and executive officers in attendance were introduced, including the CEO, CFO, and COO.
Inspector of Elections and representatives from independent auditors and legal counsel were present.
Shareholder proposals
Four proposals were presented: election of a Class I director, approval of a reverse stock split, ratification of auditors, and advisory approval of executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Dyadic International
- Q3 2024 revenue rose 393% to $1.96M, net loss narrowed, and cash reached $10M.DYAI
Q3 20249 Jul 2026 - Revenue up 18% on grants; product launches and strong liquidity expected in 2025.DYAI
Q1 20259 Jul 2026 - Shifted to commercial focus with new product launches, wider net loss, and strong liquidity.DYAI
Q3 20258 Jul 2026 - Q2 2025 revenue surged and net loss narrowed as commercial focus and new funding accelerated growth.DYAI
Q2 20252 Jul 2026 - Commercialization accelerates with new product launches and partnerships, targeting rapid revenue growth.DYAI
IAccess Alpha Virtual MicroCap Conference30 Jun 2026 - Facing potential Nasdaq delisting for bid price and equity deficiencies, with a hearing planned.DYAI
Proxy filing18 Jun 2026 - Commercial stage reached with six product launches, global distribution, and early recurring revenues.DYAI
Lytham Partners Spring 2026 Investor Conference28 May 2026 - Commercializing animal-free proteins with scalable platforms and recurring revenues across key markets.DYAI
Sidoti Micro-Cap Virtual Conference20 May 2026 - Commercial-stage protein innovator drives growth with animal-free products and global partnerships.DYAI
Investor presentation20 May 2026